Korean officials launch Hanmi probe in wake of tox reports; Prothena CEO Schenk dies
As we reported late last week, Boehringer Ingelheim had to do some explaining about its abrupt decision to cancel a $730 million deal with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
